Walleye Capital’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Walleye Capital’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-49,162	Closed	-$31K	–	2026
2021 Q2	$31K	Buy	49,162 +35,011	+247%	+$25.1K	﹤0.01%	1272
2021 Q1	$13K	Sell	14,151 -3,081	-18%	-$3.41K	﹤0.01%	1141
2020 Q4	$17K	Sell	17,232 -6,000	-26%	-$4.54K	﹤0.01%	909
2020 Q3	$17K	Buy	+23,232	New	+$16.2K	﹤0.01%	795

Walleye Capital's CHAQ.WS Position: Q3 2021 in Review

Walleye Capital sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 49,162 shares — an estimated $31K sold.

Walleye Capital first reported a position in CHAQ.WS in Q3 2020 and held it in 4 quarters. The position peaked at $31K in Q2 2021. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

Walleye Capital reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
Walleye Capital sold 49,162 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $31K.
Walleye Capital first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q3 2020 and held it in 4 quarters.
Walleye Capital's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $31K in Q2 2021.
0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Walleye Capital's 13F filing for Q3 2021, filed 15 Nov 2021.